AN ASSESSMENT OF THE SERIOUS INFECTION RATE IN RITUXIMAB-TREATED RHEUMATOID ARTHRITIS (RA) PATIENTS WHO SUBSEQUENTLY RECEIVED OTHER BIOLOGIC THERAPIES: A FOLLOW-UP FROM RITUXIMAB CLINICAL TRIALS

Author(s):
Genovese, M.C.; Breedveld, F.C.; Emery, P.; Cohen, S.B.; Keystone, E.C.; Matteson, E.L.; Burke, L.S.; Chai, A.; Reiss, W.G.; Sweetser, M.T.; Shaw, T.M.
Published
2010
Publication type
Other
Date issued
2010-04-30
Language
English
hdl
1887/116791